OncoSil Medical Ltd (AU:OSL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OncoSil Medical Ltd has announced a significant change in the shareholding interests of Director Douglas Cubbin, who acquired an additional 25 million shares and 32.5 million options. The company has identified a previous discrepancy in the directors’ interest disclosures and is implementing enhanced compliance measures to prevent future occurrences. This move reflects OncoSil’s commitment to transparency and adherence to corporate governance standards, potentially influencing investor confidence.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.